---
figid: PMC8144890__gr3
figtitle: Energy metabolism disorders and potential therapeutic drugs in heart failure
organisms:
- Candida dubliniensis
- Panax ginseng
- Salvia miltiorrhiza
- Theobroma cacao
- Lycium barbarum
- Schisandra chinensis
- Ligusticum sinense
- Ophiopogon japonicus
- Lycium chinense
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Canis lupus familiaris
pmcid: PMC8144890
filename: gr3.jpg
figlink: /pmc/articles/PMC8144890/figure/fig3/
number: F3
caption: AMPK and mTOR signaling pathway. When energy is insufficient, AMPK can be
  activated to increase the intake of fatty acids and glucose, inhibit glycogen synthesis,
  promote fatty acid oxidation and increase energy production. At the same time, it
  can promote the synthesis of mitochondria by regulating PGC-α. AMPK activation,
  hypoxia conditions and insulin can also inhibit mTORC1 activation, so as to regulate
  fatty acid metabolism, protein synthesis, autophagy, etc. Insulin can also directly
  activate mTORC2, regulate cell survival and cytoskeleton formation.
papertitle: Energy metabolism disorders and potential therapeutic drugs in heart failure.
reftext: Yanan He, et al. Acta Pharm Sin B. 2021 May;11(5):1098-1116.
year: '2021'
doi: 10.1016/j.apsb.2020.10.007
journal_title: Acta Pharmaceutica Sinica. B
journal_nlm_ta: Acta Pharm Sin B
publisher_name: Elsevier
keywords: Heart failure | Energy deficit | Cardiac dysfunction | Energy metabolism
  | Substrate metabolism | Hormones | Natural products | Synthetic drugs
automl_pathway: 0.9577241
figid_alias: PMC8144890__F3
figtype: Figure
organisms_ner:
- Homo sapiens
- Rattus norvegicus
- Mus musculus
- Canis lupus familiaris
redirect_from: /figures/PMC8144890__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8144890__gr3.html
  '@type': Dataset
  description: AMPK and mTOR signaling pathway. When energy is insufficient, AMPK
    can be activated to increase the intake of fatty acids and glucose, inhibit glycogen
    synthesis, promote fatty acid oxidation and increase energy production. At the
    same time, it can promote the synthesis of mitochondria by regulating PGC-α. AMPK
    activation, hypoxia conditions and insulin can also inhibit mTORC1 activation,
    so as to regulate fatty acid metabolism, protein synthesis, autophagy, etc. Insulin
    can also directly activate mTORC2, regulate cell survival and cytoskeleton formation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MUC1
  - MLYCD
  - CPT1B
  - SLC2A4
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - ACACB
  - BCL2A1
  - F2
  - WDTC1
  - APRT
  - MFAP1
  - ATP8A2
  - TSC2
  - TSC1
  - CCL26
  - TBC1D7
  - PFKFB3
  - TNF
  - RHEB
  - RHEBP1
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - CHUK
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - Mlycd
  - Slc2a4
  - Prkaa2
  - Acacb
  - Svs4
  - Tmprss5
  - Tsc2
  - Tsc1
  - Tbc1d7
  - Pfkfb2
  - Tnf
  - Rheb
  - Akt1
  - Pik3cg
  - Chuk
  - Cpt1a
  - Cpt1b
  - Wdtc1
  - Mdga2
  - Pik3r1
---
